Skip to main content
logo
COSCIENS Biopharma Inc. (CSCIF)
OTCMKTS · Delayed Price · Currency is USD
2.050
-0.190 (-8.48%)
At close: Nov 17, 2025

COSCIENS Biopharma Revenue

COSCIENS Biopharma had revenue of $1.48M in the quarter ending September 30, 2025, a decrease of -20.74%. This brings the company's revenue in the last twelve months to $9.05M, down -3.97% year-over-year. In the year 2024, COSCIENS Biopharma had annual revenue of $9.59M with 34.22% growth.

Revenue (ttm)
9.05M
Revenue Growth
-3.97%
P/S Ratio
0.74
Revenue / Employee
226.35K
Employees
40
Market Cap
6.69M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.59M2.44M34.22%
Dec 31, 20237.14M-7.43M-50.98%
Dec 31, 202214.57M9.31M177.03%
Dec 31, 20215.26M1.61M44.03%
Dec 31, 20203.65M3.12M586.47%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Glass House Brands196.17M
Elite Pharmaceuticals122.89M
Mid-Atlantic Home Health Network27.00M
Silence Therapeutics25.83M
China New Energy Group Co.12.51M
Nuo Therapeutics2.61M
Revenue Rankings

COSCIENS Biopharma News

More News